| Literature DB >> 34209137 |
Dina Medina-Vera1,2,3,4, Juan Antonio Navarro1,3, Rubén Tovar1,3, Cristina Rosell-Valle1, Alfonso Gutiérrez-Adan5, Juan Carlos Ledesma1, Carlos Sanjuan6, Francisco Javier Pavón1,4, Elena Baixeras7, Fernando Rodríguez de Fonseca1, Juan Decara1.
Abstract
D-Pinitol (DPIN) is a natural occurring inositol capable of activating the insulin pathway in peripheral tissues, whereas this has not been thoroughly studied in the central nervous system. The present study assessed the potential regulatory effects of DPIN on the hypothalamic insulin signaling pathway. To this end we investigated the Phosphatidylinositol-3-kinase (PI3K)/Protein Kinase B (Akt) signaling cascade in a rat model following oral administration of DPIN. The PI3K/Akt-associated proteins were quantified by Western blot in terms of phosphorylation and total expression. Results indicate that the acute administration of DPIN induced time-dependent phosphorylation of PI3K/Akt and its related substrates within the hypothalamus, indicating an activation of the insulin signaling pathway. This profile is consistent with DPIN as an insulin sensitizer since we also found a decrease in the circulating concentration of this hormone. Overall, the present study shows the pharmacological action of DPIN in the hypothalamus through the PI3K/Akt pathway when giving in fasted animals. These findings suggest that DPIN might be a candidate to treat brain insulin-resistance associated disorders by activating insulin response beyond the insulin receptor.Entities:
Keywords: D-Pinitol; PI3K/Akt pathway; hypothalamus; inositol; insulin resistance
Year: 2021 PMID: 34209137 DOI: 10.3390/nu13072268
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717